Clark exits Merck Dec. 1, passing chairman title to CEO

Merck ($MRK) Chairman Richard Clark (photo) will retire Dec. 1, leaving Kenneth Frazier (photo) with the dual role of chairman and CEO. Frazier took the operational reins at Merck in January after the company's mandatory retirement age forced Clark to step down. Report | Item

Suggested Articles

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

Data on Roche's Polivy aren't yet enough to win support from England's cost watchdogs, who rejected the medicine based on long-term…